Protherics’ DigiFab™ to Become Market Leader in Europe
By Business Review Editor
Pharma Deals Review: Vol 2007 Issue 79 (Table of Contents)
Published: 7 Jan-2007
DOI: 10.3833/pdr.v2007.i79.405 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
Protherics expanded its core franchise through the transfer of the market rights for Digitalis Antidot® from Roche...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018